Molecules / Zolmitriptan

Zolmitriptan API manufacturers

CAS 139264-17-8 ATC N02CC03 Updated 9 July 2026
14
manufacturers with an active filing 13 of them hold a US DMF or a CEP
$7434.87
median export price per kg $3494.65 to $14636.74 · 14 exporters · 2025
102
shortage records on file across 9 countries
216
finished-dose makers across 35 regulators
Showing 14 of 14 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Alembic Pharmaceuticals

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF and 2 valid CEPs for zolmitriptan, filing since 2011. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.

US DMF
1 active
CEP
2 valid
Last FDA inspection
2025 · VAI
GMP recognised in
18 markets
How this listing is sourced EDQM certificate database
FDA, List of Drug Master Files
View profile
02

Dr. Reddy's Laboratories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for zolmitriptan, filing since 2012. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
26 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Macleods Pharmaceuticals

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for zolmitriptan, filing since 2011. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · VAI
GMP recognised in
29 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Hetero

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for zolmitriptan, filing since 2011. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
6 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Natco Pharma

India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for zolmitriptan, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 15 markets.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
15 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Alivus Life Sciences

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for zolmitriptan, filing since 2008. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
2 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
07

Apitoria Pharma

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF and one valid CEP for zolmitriptan, filing since 2013. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
1 valid
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
08

Orbion Pharmaceuticals

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for zolmitriptan, filing since 2011.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
09

Jubilant Generics

India
Makes the APIFinished dose

Registered with SFDA (Saudi Arabia) for zolmitriptan. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 10 markets.

US DMF
None on file
CEP
None on file
Last FDA inspection
2024 · VAI
GMP recognised in
10 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
10

Jubilant Biosys

India
Makes the API

Holds 2 active US DMFs for zolmitriptan, filing since 2010. Its 2022 FDA inspection closed as VAI.

US DMF
2 active
CEP
None on file
Last FDA inspection
2022 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
11

Matrix Pharmacorp

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for zolmitriptan, filing since 2007. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
13

Inke

Spain
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for zolmitriptan, filing since 2011. Its 2023 FDA inspection closed as VAI.

US DMF
2 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
14

SMS Pharmaceuticals

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for zolmitriptan, filing since 2007. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 6 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · OAI
GMP recognised in
6 markets
How this listing is sourced FDA, List of Drug Master Files
View profile

11 more manufacturers hold filings for zolmitriptan

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

HeteroNatco PharmaAlivus Life SciencesApitoria PharmaOrbion PharmaceuticalsJubilant GenericsJubilant BiosysMatrix PharmacorpSyn-Tech Chem. & PharmInkeSMS Pharmaceuticals
Open the full list with a free account

Contract manufacturers (2)

Jewim Pharmaceutical (Shandong) China Inke Spain

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (19)

Glenmark Pharmaceuticals s.r.o Czech Republic Zydus Lifesciences India Ajanta Pharma India Amneal United States Cipla India Jewim Pharmaceutical (Shandong) China Zentiva, k.s Czech Republic Apotex Canada Teva Israel Viatris United States Sandoz Switzerland Grünenthal Germany Astrazeneca Ab Sweden Jamp Pharma Canada Mint Pharmaceuticals Canada STADA Arzneimittel Germany Farmak Czech Republic Aurobindo Pharma India Chartwell RX United States

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators
Price band
Customs export unit values for 2025. These are export values rather than contract prices for regulated-market grade material, which are higher.

Map zolmitriptan for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Price history 4 yrs Shortages 102 Recalls 2 Finished dose 19 Contract mfrs 2

By country

India 21

Export price by year

Year Median Exporters
2025 $7434.87 14
2024 $8188.31 13
2023 $7604.94 12
2022 $8584.85 8

US dollars per kilogram, customs export unit values.